Purpose: We performed both, dosimetric and positional accuracy verification of dynamic tumor tracking (DTT) intensity modulated radiation therapy (IMRT), with the Vero4DRT system using a moving phantom (QUASAR respiratory motion platform; QUASAR phantom) and system log files. Methods: The QUASAR phantom was placed on a treatment couch. Measurement of the point dose and dose distribution was performed for conventional IMRT, with the QUASAR phantom static and moving; for DTT IMRT, this was performed with the phantom moving for pyramid shaped, prostate, paranasal sinus, and pancreas targets. The QUASAR phantom was driven by a sinusoidal signal in the superior-inferior direction. Furthermore, predicted positional errors induced by the Vero4DRT system and mechanical positional errors of the gimbal head, were calculated using the system log files. Results and Conclusion: For DTT IMRT, the dose at the evaluation point was within 3% compared with the verification plan, and the dose distribution in the passing rates of γ was 97.9%, with the criteria of 3% dose and 3 mm distance to agreement. The position error calculated from the log files was within 2 mm, suggesting the feasibility of employing DTT IMRT with high accuracy using the Vero4DRT system.
Introduction
Tumor respiratory motion management is essential during radiotherapy for thoracic or abdominal tumors. Expanding the area of irradiation to cover the entire volume of respiration-induced tumor motion exposes the peripheral normal tissue to high doses along with the tumor, and may lead to adverse events [1] . Methods for respiratory tumor motion management include inhalation of oxygen, abdominal compression, coaching for regular respiratory patterns, breath holding, respiratory gating, and real-time tumor-tracking [2] . Respiratory motion management is frequently associated with poor reproducibility, increased burden on the patient owing to breath holding, and/or prolonged irradiation time. Respiratory motion management of the tumor is particularly relevant to intensity modulated radiation therapy (IMRT), as it may provide excellent dose distributions for the most complex cancer volumes; it also potentially increases the therapeutic ratio drastically when the target is immobile [3] . However, the advantages of IMRT may be annulled unless organ motion is addressed; organ motion may lead to normal tissue under-or over-dosing during beam delivery, during the entire course of treatment [4] .
The Vero4DRT system (Hitachi, Ltd., Tokyo, Japan) delivers treatment while the patient breathes freely, by tracking the target in real time using radiopaque fiducial markers for identification of the tumor, enabling dynamic tumor tracking (DTT). Equipped with a compact linear accelerator on the rotatory O-ring gantry and a gimbal mechanism, the light-weight X-ray head can change the beam direction [5] [6] . DTT irradiation has achieved reduced irradiation times, high irradiation reproducibility, and has reduced the burden on the patient [7] . A system of dynamic tumor tracking intensity modulated radiation therapy (DTT IMRT) has been developed by combining intensity modulated radiation therapy (IMRT) with DTT. DTT IMRT is effective for pancreatic tumors, as the radiation dose to these tumors is limited by the radiosensitivity of the surrounding gastrointestinal organs [8] ; therefore, previous attempts to increase radiation doses using conventional techniques were unsuccessful, and have resulted in high morbidity and mortality [9] . However, simultaneous delivery of IMRT and DTT is expected to increase the burden on the multi-leaf collimator (MLC) and the gimbal mechanism, causing an interplay effect. Mukumoto et al. [10] [12] . In this study, we have verified point doses and dose distributions using an ionization chamber dosimeter and EBT3 film, respectively, during DTT IMRT. Furthermore, the precision of irradiation was calculated using the system log files.
Materials and Methods

Dynamic Tumor Tracking Intensity Modulated Radiation Therapy Using the Vero4DRT System
DTT was used to monitor (20 -40 s) the motions of infrared reflecting (IR) markers set on the abdominal wall and the motions of fiducial markers positioned close to the tumor at 16.7 ms and 320 ms or 640 ms intervals, respectively, immediately before irradiation. A four-dimensional correlation model (4D model) was then created using positions of the IR and fiducial markers [13] . The position of the fiducial markers were registered in advance on ExactracVero (Brainlab AG, Munich, Germany) using planning computed tomography (CT) images, and the positional relation to the tumor center (isocenter) was defined. During irradiation, the gimbaled X-ray head tracked the tumor based on the 4D model, and delivered IMRT in the step-and-shoot mode.
Verification Plans and Irradiation Conditions
Planning CT images were acquired using 16-slice CT BrightSpeed Elite SD (GE Healthcare UK Ltd., Buckinghamshire, England). The settings for acquisition of the planning CT were as follows: 120 kV, Auto mA, and 0.5 ms. The scan parameters were set as follows: 9.37 mm/rot helical pitch, 10 mm beam collimation, 16 × 0.625 mm detector collimation, and 2.5 mm slice thickness. The IMRT plans were created using iPlan RT Dose Ver. 4.5.3 (Brainlab AG, Munich, Germany) using the X-ray voxel Monte Carlo (XVMC) algorithm for 6-MV beams.
The spatial resolution and variance of dose calculation were set to 2 mm and 2%, respectively. To investigate the effects of IMRT complexity, DTT IMRT verification plans were prepared for one case each of pyramid shaped, prostate, paranasal sinus, and pancreatic cancer targets, respectively. Details of the plans are shown in Table 1 . The average mean leaf gap width [14] was calculated as an index of IMRT complexity. The average mean leaf gap width represents the segment average of the mean leaf gap width, and is calculated by dividing the gap width of each segment by the gap width of the Y-Jaw. Here, the maximum gap width of the MLC was assumed to be the gap width of the Y-Jaw, as Ve-ro4DRT creates the irradiation field using only 5 mm-wide MLCs. A dynamic phantom, namely, the QUASAR respiratory motion platform (Modus Medical Devices Inc., Ontario, Canada; QUASAR phantom) was then set on a treatment couch, and the I'mRT phantom (IBA Dosimetry GmbH, Schwarzenbruck, Germany) was installed on the horizontal driving shaft of the QUASAR phantom. Subsequently, a plate to which five IR markers were affixed, was set on the vertical driving shaft ( Figure 1 ). On the upper surface of the I'mRT phantom, 4 radiopaque x-spot (Beekley Medical, Connecticut, USA) spheres measuring 1.5 mm in diameter were affixed, and the positions were registered as fiducial markers on ExactracVero. The following three irradiation patterns were created using different combinations of the QUASAR phantom motion state and IMRT irradiation pattern: a) Static IMRT: conventional IMRT irradiation with the QUASAR phantom static.
b) Non-DTT IMRT: conventional IMRT irradiation with the QUASAR phantom moving. c) DTT IMRT: DTT IMRT irradiation with the QUASAR phantom moving. 
Point Dose Verification
An ionization chamber dosimeter CC13 (IBA Dosimetry GmbH, Schwarzenbruck, Germany) and Fluke Type 35040 (Fluke Biomedical, Ohio, USA) electrometers were employed. The active volume of the CC13 dosimeter is 0.13 cm 3 ; the chamber was placed at the center of the I'mRT phantom (depth: 9 cm). The measured and computed doses were then compared using the verification plan. The tolerance for dose error was set to less than ±5% and ±3% for single beams and summation of all beams, respectively [15] .
Dose Distribution Verification
The dose distribution in the coronal plane was obtained by placing an EBT3 film at the center of the I'mRT phantom (depth: 9 cm). The films were scanned in transmission mode at a resolution of 72 dpi on the 16-bit red-channel color scale, with a constant 24-h post-exposure period using EPSON ES-10000G
(SEIKO EPSON CORPORATION, Nagano, Japan). Each pixel value was normalized to the planned dose at the isocenter. The DD-system (R-TECH. INC, Nagano, Japan) was then used to analyze γ evaluation [16] . The tolerance of the γ pass rate, using 3% dose and 3 mm distance to agreement with 30% dose threshold, was set to greater than 90%.
Analysis of Positional Error of DTT IMRT Using Log Files
The positional accuracy of DTT IMRT was estimated based on the predicted positional error of the 4D model, mechanical positional error of the gimbal mechanism, and baseline shifts in the patient's respiration [17] . The mean and standard deviation (SD) for the predicted and mechanical positional errors were calculated using the system log files. The position of the target recorded in the log files was assumed to be the reference position of the target on kV X-ray images. The difference between the reference and predicted positions of the target calculated from the positions of the IR markers and 4D model, was defined as the predicted positional error of the model [13] . Moreover, the differences between the system command and actual values at 5 ms intervals during DTT IMRT were defined as the mechanical positional error [7] . The correlation coefficient R, between target velocity and acceleration for predicted and mechanical positional errors, respectively, was also determined.
Results
Average of Mean Leaf Gap Width
The average of mean leaf gap widths in the IMRT plan for the pyramid shaped, prostate, paranasal sinus, and pancreatic cancer targets were 38.8, 29.6, 24.5, and 26.2 mm, respectively.
Point Dose Verification
The dose errors for static, Non-DTT, and DTT IMRT in the individual plans are shown in Figure 2 . The dose errors for static IMRT were within the tolerance on all verification plans. For Non-DTT IMRT, the dose errors were within the tolerance only for the pyramid shaped plans. Conversely, the dose errors for the other cancer targets were within the tolerance for accumulated dose from all beams; however, the dose error from single beams exceeded the limit. In particular, larger amplitude resulted in greater standard deviations of the dose error with single beams. However, the dose errors were within the tolerance for all verification plans using DTT IMRT, and differences in dose errors by variation of amplitude were also insignificant. which was along the driving shaft of the QUASAR phantom, showed reductions and increases in the flat and penumbra areas, respectively, as the amplitude increased. The γ pass rates for amplitudes of 10 mm (93.9% ± 2.02%) were within the tolerance; however, they were lower than the γ pass rates (97.9% ± 1.16%) of static IMRT. The rates at amplitudes of 20 mm and 40 mm were below the tolerance, at 68.3% ± 7.82% and 45.7% ± 9.50%, respectively. On DTT IMRT, the dose profiles agreed well with the verification plans. The γ pass rates were greater than 94% on all verification plans.
Dose Distribution Verification
Analysis of Positional Errors of DTT IMRT Using Log Files
The predicted positional errors and velocity/acceleration of the target during DTT IMRT are shown in Table 2 . Larger amplitudes led to larger predicted positional errors. The mean + 2SD of the predicted positional error was the largest, 
Discussion
Point Dose Verification
For the pyramid shaped plans, insignificant differences in dose error were observed between Non-DTT and DTT IMRT. This may be explained by the fact that the segment at the center of the pyramid had a shape that did not affect the dose even when the QUASAR phantom was driven at an amplitude of 40 mm.
In Non-DTT IMRT, the point doses were not entirely within the tolerance limit for any of the cancer cases, even at amplitudes of 10 mm. This was probably related to the positional difference between the MLC and target; doses were therefore delivered at different positions (phases) compared with the verification plan, resulting in an interplay effect. However, the accumulated dose from summation of all beams was within the tolerance. Mukumoto et al. also reported that the peripheral dose to the planning target volume (PTV) was reduced under moving conditions [10] .
The maximum dose error per beam and SD were larger for the paranasal sinus cancers than for the other cases. This was probably related to the complexity of IMRT for paranasal sinus cancers, where the mean leaf gap was as narrow as 24.5 mm. The smaller gap compared to the other cases was likely to cause larger dose errors. In DTT IMRT, the point doses were consistent with that of the verification plan, and were also within the tolerance. However, the experimental system in this study was practically limited to the clinical situation on two points: 1) the motions of the target and IR markers were synchronized by the QUASAR phantom, 2) it involved motions only along the SI direction.
Dose Distribution Verification
Several reports [18] - [26] suggest that while irradiating during respiratory movement, the blurring effect decreases the PTV marginal dose and the penumbra expands, resulting in a difference from the planned dose distribution. The level of inconsistency depends on the respiration amplitude and complexity of intensity modulation. In this study, the profile along the SI direction, or along the driving shaft of the QUASAR phantom, showed an expanded penumbra compared to the verification plan for Non-DTT IMRT. The profile along the left-right direction was consistent with that of the pyramid shaped plan. This was probably related to the fact that the pyramid shaped plan consisted of rectangular field segments; therefore, a number of leaves had mutually similar left-right coordinates.
In other plans, the fluctuations in dose distribution were directly proportional to the amplitude, and notable reductions were observed in the γ pass rate. In DTT IMRT, the γ pass rates were consistent with that of the verification plans, and were within the tolerance. Mukumoto et al. reported that the dosimetric accuracy showed significant improvements, of up to 92.9% ± 4.0% with tracking versus 69.8% ± 7.4% without tracking, using γ pass rates with criteria of 3%/1 mm (p < 0.001). In their study, static, Non-DTT, and DTT IMRT films were compared.
Conversely, in this study, the verification plans and individual films were compared. Colvill et al. conducted a multi-institutional dosimetric comparison study between real-time adaptive and non-adaptive radiotherapy [27] ; respiratory motion resulted in much higher γ-fail rates without motion adaptation. However, these rates were comparable for conventional IMRT under static conditions [27] [28]. The AAPM TG-119 protocol described for IMRT commissioning showed that the action level was 88% -90% of the γ pass rate, with a tolerance of 10% of the dose threshold using the 3%/3 mm criterion [28] . According to the European Society for Radiotherapy and Oncology guidelines, γ pass rates < 90% are not acceptable [29] . The dose distribution in our study was consistent with that of their study.
Doses could be delivered with accuracy equivalent to that of static IMRT; this indicates that DTT IMRT may minimize dosimetric errors from interplay, and reliable IMRT delivery may be achieved for moving targets.
Analysis of Positional Errors of DTT IMRT Using Log Files
The predicted positional error of the 4D model poorly correlated with the velocity of the target; however, it was highly correlated with target acceleration. This was probably related to the fact that increased acceleration of the target reduced the prediction accuracy of the system at the peak of the respiratory waveform (expiratory and inspiratory phases). Mukumoto et al. reported that the mean + 2SD of the predicted positional error of the 4D model in the Vero4DRT system was within the 2 mm range under conditions of synchronicity between the motion of the target and IR marker [13] . Depuydt et al. [11] reported that the tracking error 90% percentile E (90%) was < 0.82 mm. Garibaldi et al. [12] reported that the RMS of prediction and mechanical errors were up to 0.8, 0.5, and 0.9 mm for all non-phased-shifted motion patterns. Similar synchronicity was also maintained in this study, and the maximum mean + 2SD of the predicted positional error was 0.82 mm, even under the severest conditions of amplitude and period of 40 mm and 4 s, respectively; our results were therefore consistent with that of their study.
Mechanical positional errors were highly correlated with the velocities of the target; however, the correlation with the accelerations of the target was low. This was related to the delay in response of 5 ms in real time that is required by the gimbal mechanism to change the direction of the beam towards the target position, as predicted by the system during DTT irradiation. On rapid movement of the target in 5 ms, the positional difference from the predicted position became large, resulting in high correlation between the mechanical positional error and the velocity of the target. However, even at the severest condition of amplitude and period of 40 mm and 4 s, respectively, the mean + 2SD of the mechanical positional error was only 1.02 mm, confirming the high accuracy of the gimbal mechanism. In practice, the system was controlled during DTT irradiation to ensure that the beam was held when the mechanical positional error exceeded 2 mm during delivery of megavoltage X-rays. Also in medical practice, patients are coached to breathe slowly and smoothly (for a smooth and long respiratory waveform) to control the velocity of the target.
Conclusion
Compared to the verification plans, the point doses and dose distributions of DTT IMRT by Vero4DRT in this study were within the tolerance limits. In addition, the positional errors calculated from the log files were small, suggesting that DTT IMRT may deliver doses with high accuracy comparable to static IMRT.
